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A 63-year-old woman with long-standing
ulcerative colitis was found by routine, highdeﬁnition white light surveillance colonoscopy to have high-grade dysplasia (HGD)

on a random biopsy of ﬂat, erythematous
mucosa of the rectosigmoid colon. Several
previous surveillance colonoscopies had
consistently shown mild-moderate pancolitis and pseudopolyposis without dysplasia. The patient’s bowel complaints were
moderately controlled by oral mesalamine,
with multiple previous refusals to escalate
therapy to achieve mucosal healing. After a
second gastrointestinal pathologist review
conﬁrming HGD, the case was discussed at
our institution’s multidisciplinary inﬂammatory bowel disease (IBD) conference, after which the patient was oﬀered
colectomy. The patient, however, refused
and was referred to the advanced endoscopy
service for chromoendoscopy and possible
endoscopic resection. Shortly after the referral, the novel coronavirus disease 2019
(COVID-19) pandemic arose, and the patient chose to postpone her colonoscopy by
3 months because of the fear of contracting
the novel coronavirus. When it was ﬁnally
performed, a new 3 cm sessile lesion (Paris
class IIb) in the rectosigmoid colon was
identiﬁed (Figure 1). It was removed via
endoscopic mucosal resection with snare tip
coagulation of the resection border. Pathology revealed moderately diﬀerentiated
adenocarcinoma. The patient was referred
to colorectal surgery for colectomy.
Dysplasia identiﬁed on random (nontargeted) biopsies of the colon mucosa
without a visible lesion is deﬁned as invisible dysplasia (1). The risk of undetected,
synchronous colorectal cancer (CRC) in a
patient with invisible HGD has been estimated to be as high as 42% (2). This high
CRC risk prompted early guidelines and
expert opinion to recommend that invisible

HGD proceed immediately to colectomy.
The 2015 Surveillance Colorectal Endoscopic Neoplasia Detection and Management in Inﬂammatory Bowel Disease
Patients: International Consensus Recommendations (SCENIC) however suggests
that patients with IBD and invisible dysplasia may be referred to an expert endoscopist for image-enhanced colonoscopy
using chromoendoscopy to better guide
decision-making for treatment or surveillance plans (1). If a visible dysplastic lesion
is found by chromoendoscopy at the site of
previously invisible dysplasia, this may allow for endoscopic resection and further
surveillance rather than colectomy.
The COVID-19 pandemic has halted
the practice of endoscopy throughout the
world. The concern for infection transmission during endoscopy, the need to
conserve personal protective equipment,
and the availability of endoscopy unit infrastructure had to be weighed against the
ongoing need for endoscopic evaluation
and therapy. The American Gastroenterology Professional Associations released a
joint statement that brieﬂy deﬁned elective
vs urgent/emergent procedures and provided their recommendations for which
types of procedures should be delayed (3).
The statement recommends that evaluation of IBD with dysplasia should not be
delayed. Despite these recommendations,
many procedures are being delayed because
of resources being diverted to the care
for patients with COVID-19 or patient
preference/fear, as occurred in this case.
This case demonstrates that patients
with IBD and HGD referred for possible
endoscopic resection should not be delayed

Figure 1. Rectosigmoid adenocarcinoma in an area of previously invisible high-grade dysplasia as seen on follow-up colonoscopy in (a) high-definition white
light, (b) narrow-band imaging, and (c) after endoscopic mucosal resection.
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during the COVID-19 pandemic. Compared with the dysplasia to cancer progression in sporadic CRC, HGD in IBD has
a much more rapid progression (4). Proper
patient education is required to inform
them of the risks of delayed endoscopic
evaluation for IBD with HGD during the
COVID-19 pandemic.
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